Going beyond manufacturers' limitations is not in the best interest of our patients

Comment

Gerard J Myers. J Extra Corpor Technol. 2014 Mar.

. 2014 Mar;46(1):101-2.

No abstract available

Comment in

Response to letter "Going beyond manufacturers' limitations is not in the best interests of our patients" by Gerard J. Myers.
Bronson SL, Scott PD, Blessing JP, Riley JB. Bronson SL, et al. J Extra Corpor Technol. 2014 Mar;46(1):103-4. J Extra Corpor Technol. 2014. PMID: 24779129 No abstract available.

Prescriptive patient extracorporeal circuit and oxygenator sizing reduces hemodilution and allogeneic blood product transfusion during adult cardiac surgery.
Bronson SL, Riley JB, Blessing JP, Ereth MH, Dearani JA. Bronson SL, et al. J Extra Corpor Technol. 2013 Sep;45(3):167-72. J Extra Corpor Technol. 2013. PMID: 24303598 Free PMC article.

1. McIlroy DR, Kharasch ED.. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg. 2003;96:1572–1577. - PubMed
1. Straub D, Boudreau MC, Gefen D.. Validation guidelines for IS Positivist research. Comm Assn Info Syst. 2004;13:380–427.
1. Myers GJ.. Predictive Hemodilution—The Principles and Practice of Hemodilution during Cardiac Surgery. Mirandola, Italy: Sorin Group Perfusion Books; 2013.
1. Klepinski R: Off-label use of medical devices in the USA. Journal Med Device Reg. 2009;6:8–19.
1. U.S. Department of Health and Human Services (FDA). Off-label and investigational use of marketed drugs, biologics, and medical devices. 2011. Available at: www.fda.gov/RegulatoryInformation/Guidances/ucm126486.htm.